330 related articles for article (PubMed ID: 29578103)
21. Decline of resting inspiratory capacity in COPD: the impact on breathing pattern, dyspnea, and ventilatory capacity during exercise.
O'Donnell DE; Guenette JA; Maltais F; Webb KA
Chest; 2012 Mar; 141(3):753-762. PubMed ID: 21852298
[TBL] [Abstract][Full Text] [Related]
22. Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests.
Porto EF; Castro AA; Nascimento O; Oliveira RC; Cardoso F; Jardim JR
Respir Med; 2009 Feb; 103(2):251-7. PubMed ID: 18930646
[TBL] [Abstract][Full Text] [Related]
23. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease.
O'Donnell DE; Voduc N; Fitzpatrick M; Webb KA
Eur Respir J; 2004 Jul; 24(1):86-94. PubMed ID: 15293609
[TBL] [Abstract][Full Text] [Related]
24. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease.
O'Donnell DE; Lam M; Webb KA
Am J Respir Crit Care Med; 1999 Aug; 160(2):542-9. PubMed ID: 10430726
[TBL] [Abstract][Full Text] [Related]
25. Faster reduction in hyperinflation and improvement in lung ventilation inhomogeneity promoted by aclidinium compared to glycopyrronium in severe stable COPD patients. A randomized crossover study.
Santus P; Radovanovic D; Di Marco F; Raccanelli R; Valenti V; Centanni S
Pulm Pharmacol Ther; 2015 Dec; 35():42-9. PubMed ID: 26549785
[TBL] [Abstract][Full Text] [Related]
26. Physiological effects of roflumilast at rest and during exercise in COPD.
O'Donnell DE; Bredenbröker D; Brose M; Webb KA
Eur Respir J; 2012 May; 39(5):1104-12. PubMed ID: 21965226
[TBL] [Abstract][Full Text] [Related]
27. Budesonide added to formoterol contributes to improved exercise tolerance in patients with COPD.
Worth H; Förster K; Eriksson G; Nihlén U; Peterson S; Magnussen H
Respir Med; 2010 Oct; 104(10):1450-9. PubMed ID: 20692140
[TBL] [Abstract][Full Text] [Related]
28. Volume effect and exertional dyspnoea after bronchodilator in patients with COPD with and without expiratory flow limitation at rest.
Boni E; Corda L; Franchini D; Chiroli P; Damiani GP; Pini L; Grassi V; Tantucci C
Thorax; 2002 Jun; 57(6):528-32. PubMed ID: 12037229
[TBL] [Abstract][Full Text] [Related]
29. Effect of Vaporized Cannabis on Exertional Breathlessness and Exercise Endurance in Advanced Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial.
Abdallah SJ; Smith BM; Ware MA; Moore M; Li PZ; Bourbeau J; Jensen D
Ann Am Thorac Soc; 2018 Oct; 15(10):1146-1158. PubMed ID: 30049223
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of non-invasive ventilation as a rescue therapy for relieving dyspnea in patients with stable severe COPD.
Ou YE; Lin ZM; Wu WL; Luo Q; Chen RC
Respir Med; 2016 Dec; 121():74-80. PubMed ID: 27888995
[TBL] [Abstract][Full Text] [Related]
31. Aclidinium improves exercise endurance, dyspnea, lung hyperinflation, and physical activity in patients with COPD: a randomized, placebo-controlled, crossover trial.
Beeh KM; Watz H; Puente-Maestu L; de Teresa L; Jarreta D; Caracta C; Garcia Gil E; Magnussen H
BMC Pulm Med; 2014 Dec; 14():209. PubMed ID: 25539654
[TBL] [Abstract][Full Text] [Related]
32. Effect of indacaterol on lung deflation improves cardiac performance in hyperinflated COPD patients: an interventional, randomized, double-blind clinical trial.
Santus P; Radovanovic D; Di Marco S; Valenti V; Raccanelli R; Blasi F; Centanni S; Bussotti M
Int J Chron Obstruct Pulmon Dis; 2015; 10():1917-23. PubMed ID: 26392766
[TBL] [Abstract][Full Text] [Related]
33. Detecting improvements in dyspnea in COPD using a three-minute constant rate shuttle walking protocol.
Sava F; Perrault H; Brouillard C; Darauay C; Hamilton A; Bourbeau J; Maltais F
COPD; 2012 Aug; 9(4):395-400. PubMed ID: 22509905
[TBL] [Abstract][Full Text] [Related]
34. Effect of QVA149 on lung volumes and exercise tolerance in COPD patients: the BRIGHT study.
Beeh KM; Korn S; Beier J; Jadayel D; Henley M; D'Andrea P; Banerji D
Respir Med; 2014 Apr; 108(4):584-92. PubMed ID: 24534204
[TBL] [Abstract][Full Text] [Related]
35. A pilot study assessing the effect of bronchodilator on dynamic hyperinflation in LAM.
Baldi BG; de Albuquerque AL; Pimenta SP; Salge JM; Kairalla RA; Carvalho CR
Respir Med; 2013 Nov; 107(11):1773-80. PubMed ID: 24064347
[TBL] [Abstract][Full Text] [Related]
36. Anticholinergic versus beta 2-agonist on gas exchange in COPD: a comparative study in 15 patients.
Pillet O; Manier G; Castaing Y
Monaldi Arch Chest Dis; 1998 Feb; 53(1):3-8. PubMed ID: 9632900
[TBL] [Abstract][Full Text] [Related]
37. Effect of adjunct fluticasone propionate on airway physiology during rest and exercise in COPD.
Guenette JA; Raghavan N; Harris-McAllister V; Preston ME; Webb KA; O'Donnell DE
Respir Med; 2011 Dec; 105(12):1836-45. PubMed ID: 21917440
[TBL] [Abstract][Full Text] [Related]
38. Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD.
Maltais F; Hamilton A; Marciniuk D; Hernandez P; Sciurba FC; Richter K; Kesten S; O'Donnell D
Chest; 2005 Sep; 128(3):1168-78. PubMed ID: 16162703
[TBL] [Abstract][Full Text] [Related]
39. Assessment of acute bronchodilator effects from specific airway resistance changes in stable COPD patients.
Santus P; Radovanovic D; Henchi S; Di Marco F; Centanni S; D'Angelo E; Pecchiari M
Respir Physiol Neurobiol; 2014 Jun; 197():36-45. PubMed ID: 24726342
[TBL] [Abstract][Full Text] [Related]
40. Effects of tiotropium on hyperinflation and treadmill exercise tolerance in mild to moderate chronic obstructive pulmonary disease.
Casaburi R; Maltais F; Porszasz J; Albers F; Deng Q; Iqbal A; Paden HA; O'Donnell DE;
Ann Am Thorac Soc; 2014 Nov; 11(9):1351-61. PubMed ID: 25289942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
